| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 381 | 886 | ||
| Accounts receivable, net | 405 | 545 | ||
| Inventory | 4,080 | 4,216 | ||
| Prepaid expenses and other | 231 | 295 | ||
| Total current assets | 5,097 | 5,942 | ||
| Property and equipment, net | 349 | 363 | ||
| Right of use assets | 410 | 472 | ||
| Intangibles, net | 82 | 88 | ||
| Goodwill | 1,010 | 1,013 | ||
| Other assets | 47 | 72 | ||
| Total assets | 6,995 | 7,950 | ||
| Accounts payable | 1,214 | 1,440 | ||
| Accrued expenses | 2,874 | 3,003 | ||
| Current portion of operating lease liability | 247 | 239 | ||
| Current portion of long-term debt, net of debt issuance costs | 451 | 1,023 | ||
| Total current liabilities | 4,786 | 5,705 | ||
| Operating lease liability | 162 | 230 | ||
| Debt, net of debt issuance costs | 504 | 208 | ||
| Deferred tax liability | 4 | 4 | ||
| Total liabilities | 5,456 | 6,147 | ||
| Common stock, par value 0.0001 790,000 shares authorized as of september 30, 2025 and december 31, 2024 184,264 shares issued and outstanding as of september 30, 2025 and december 31, 2024 | 18 | 18 | ||
| Additional paid-in capital | 89,207 | 89,083 | ||
| Accumulated deficit | -87,733 | -87,351 | ||
| Accumulated other comprehensive income (loss) | 47 | 53 | ||
| Total stockholders' equity | 1,539 | 1,803 | ||
| Total liabilities and stockholders' equity | 6,995 | 7,950 | ||
CV Sciences, Inc. (CVSI)
CV Sciences, Inc. (CVSI)